313 related articles for article (PubMed ID: 32249708)
1. Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets.
Lappano R; Rigiracciolo DC; Belfiore A; Maggiolini M; De Francesco EM
Expert Opin Ther Targets; 2020 Jun; 24(6):559-572. PubMed ID: 32249708
[No Abstract] [Full Text] [Related]
2. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
3. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
4. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
Yu Y; Schuck K; Friess H; Kong B
Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment.
Houthuijzen JM; Jonkers J
Cancer Metastasis Rev; 2018 Dec; 37(4):577-597. PubMed ID: 30465162
[TBL] [Abstract][Full Text] [Related]
6. Metformin suppresses HIF-1α expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer.
Shao S; Zhao L; An G; Zhang L; Jing X; Luo M; Li W; Meng D; Ning Q; Zhao X; Lei J
FASEB J; 2020 Aug; 34(8):10860-10870. PubMed ID: 32592239
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer fibroblasts and cross-talk.
Magesh P; Thankachan S; Venkatesh T; Suresh PS
Clin Chim Acta; 2021 Oct; 521():158-169. PubMed ID: 34270953
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q
J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384
[TBL] [Abstract][Full Text] [Related]
9. GPER is involved in the functional liaison between breast tumor cells and cancer-associated fibroblasts (CAFs).
Lappano R; Maggiolini M
J Steroid Biochem Mol Biol; 2018 Feb; 176():49-56. PubMed ID: 28249728
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts in breast cancer: Challenges and opportunities.
Hu D; Li Z; Zheng B; Lin X; Pan Y; Gong P; Zhuo W; Hu Y; Chen C; Chen L; Zhou J; Wang L
Cancer Commun (Lond); 2022 May; 42(5):401-434. PubMed ID: 35481621
[TBL] [Abstract][Full Text] [Related]
11. Cancer associated fibroblasts modulate the cytotoxicity of anti-cancer drugs in breast cancer: An in vitro study.
Kashyap D; Bhattacharya S; Irinike S; Khare S; Das A; Singh G; Bal A
Breast Dis; 2024; 43(1):25-36. PubMed ID: 38517765
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer.
Yao Y; Guo Q; Cao Y; Qiu Y; Tan R; Yu Z; Zhou Y; Lu N
J Exp Clin Cancer Res; 2018 Nov; 37(1):282. PubMed ID: 30477536
[TBL] [Abstract][Full Text] [Related]
15. Stromal cells in tumor microenvironment and breast cancer.
Mao Y; Keller ET; Garfield DH; Shen K; Wang J
Cancer Metastasis Rev; 2013 Jun; 32(1-2):303-15. PubMed ID: 23114846
[TBL] [Abstract][Full Text] [Related]
16. The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives.
Fang Z; Xu J; Zhang B; Wang W; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Nov; 13(1):154. PubMed ID: 33213510
[TBL] [Abstract][Full Text] [Related]
17. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer.
Salimifard S; Masjedi A; Hojjat-Farsangi M; Ghalamfarsa G; Irandoust M; Azizi G; Mohammadi H; Keramati MR; Jadidi-Niaragh F
Pathol Res Pract; 2020 May; 216(5):152915. PubMed ID: 32146002
[TBL] [Abstract][Full Text] [Related]
18. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
Suzuki J; Tsuboi M; Ishii G
Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
[TBL] [Abstract][Full Text] [Related]
20. Biomimetic Nanoplatform for Dual-Targeted Clearance of Activated and Senescent Cancer-Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer.
Jian C; Wu T; Wang L; Gao C; Fu Z; Zhang Q; Shi C
Small; 2024 Jun; 20(25):e2309279. PubMed ID: 38214439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
